Safety and Feasibility of Argatroban as Anticoagulant in Adults With ECMO
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
This prospective, randomized, controlled pilot trial aims to assess the safety and
feasibility of Argatroban as an alternative anticoagulant to unfractionated heparin in
patients receiving extracorporeal membrane oxygenation.